SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-059415
Filing Date
2014-10-03
Accepted
2014-10-03 09:03:56
Documents
4
Period of Report
2014-09-29
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v390641_8k.htm 8-K 18177
2 EXHIBIT 3.1 v390641_ex3-1.htm EX-3.1 8095
3 EXHIBIT 99.1 v390641_ex99-1.htm EX-99.1 9832
4 GRAPHIC image_001.jpg GRAPHIC 5365
  Complete submission text file 0001144204-14-059415.txt   45062
Mailing Address 721 ROUTE 202-206, SUITE 130 BRIDGEWATER, NJ 08807
Business Address 721 ROUTE 202-206, SUITE 130 BRIDGEWATER, NJ 08807 908-864-4444
Sevion Therapeutics, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31326 | Film No.: 141138395
SIC: 8731 Services-Commercial Physical & Biological Research